KLK3 and prostate cancer: Aberrant glycoform profiling may also be used as a novel liquid biopsy approach in combination with tissue-specific glycoproteins (as in the case of the free prostate-specific antigen (free PSA for prostate cancer) or extracellular vesicles, such as exosomes [18].